Cogent Biosciences, Inc. Common Stock Share Price
NASDAQ: COGTHealthcare
Live Cogent Biosciences, Inc. Common Stock Share Price Chart
O H L
Cogent Biosciences, Inc. Common Stock Performance Overview
Days Range
▼
$32.21Low
$32.90High
Markets Today
| Previous Close | $33.19 |
|---|---|
| Open | $32.90 |
| Volume | 296,981 |
| Day's Range | $32.21 - $32.90 |
| 52W Range | $11.60 - $43.73 |
| Market Cap | $5.65 B |
Historical Performance
| 1M Returns | -11.26 |
|---|---|
| 3M Returns | -3.91 |
| 6M Returns | -3.43 |
| 1Y Returns | +160.93 |
| 5Y Returns | +269.19 |
| 10Y Returns | NA |
Cogent Biosciences, Inc. Common Stock Fundamentals
| Market Cap | $5.65 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.80 |
| EPS TTM | $-2.14 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 11.94 |
| EBITDA | $-330.80 M |
| Profit Margin | N/A |
| Market Cap | $5.65 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.80 |
| EPS TTM | $-2.14 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 11.94 |
| EBITDA | $-330.80 M |
| Profit Margin | N/A |
Cogent Biosciences, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$74.93 M | -$75.58 M | -$83.36 M | -$99.49 M | -$103.61 M | -$102.64 M |
| EBITDA | -$74.29 M | -$74.93 M | -$82.71 M | -$98.86 M | -$102.98 M | -$101.90 M |
| Interest Expense | $0 | -$314.00 K | -$1.46 M | -$1.29 M | -$1.21 M | -$1.22 M |
| Depreciation | $640.00 K | $655.00 K | $641.00 K | $628.00 K | $626.00 K | $741.00 K |
| Income Before Tax | -$71.99 M | -$73.53 M | -$80.93 M | -$102.49 M | -$97.35 M | -$96.41 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$71.99 M | -$73.53 M | -$80.93 M | -$102.49 M | -$97.35 M | -$96.41 M |
| Net Profit Margin | - | - | - | - | - | - |
Cogent Biosciences, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $114.00 K | $114.00 K | $141.00 K | $161.00 K | $171.00 K | $171.00 K |
| Reserve & Surplus | -$931.30 M | -$1.00 B | -$1.09 B | -$1.19 B | -$1.29 B | -$1.38 B |
| Non-Current Liabilities | $15.48 M | $61.36 M | $61.22 M | $237.28 M | $237.33 M | $242.86 M |
| Current Liabilities | $49.32 M | $58.42 M | $62.25 M | $63.95 M | $57.98 M | $59.30 M |
| Total Liabilities | $64.80 M | $119.78 M | $123.47 M | $301.24 M | $295.31 M | $302.16 M |
| Fixed Assets | $6.45 M | $5.85 M | $5.27 M | $5.46 M | $5.30 M | $4.78 M |
| Current Assets | $252.88 M | $245.01 M | $397.24 M | $910.36 M | $877.80 M | $804.82 M |
| Total Assets | $283.80 M | $274.82 M | $425.93 M | $937.61 M | $903.01 M | $834.55 M |
Cogent Biosciences, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$71.99 M | -$73.53 M | -$80.93 M | -$102.49 M | -$97.35 M | -$96.41 M |
| Operating Cash Flow | -$66.51 M | -$54.54 M | -$64.29 M | -$79.11 M | -$86.88 M | -$77.27 M |
| Investing Cash Flow | $69.38 M | $8.91 M | -$155.05 M | -$322.77 M | -$36.46 M | $14.28 M |
| Financing Cash Flow | $24.97 M | $47.23 M | $217.37 M | $588.67 M | $52.54 M | $2.96 M |
| Change in Cash | $27.84 M | $1.59 M | -$1.97 M | $186.79 M | -$70.80 M | -$60.04 M |
Cogent Biosciences, Inc. Common Stock Return Calculator
The Cogent Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$35,818
Invested Amount$10,000
Est. Returns$25,818
About Cogent Biosciences, Inc. Common Stock
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Popular Stocks
FAQs
What is the share price of Cogent Biosciences, Inc. Common Stock today?
Cogent Biosciences, Inc. Common Stock (COGT) share price as of September 18, 2026 is $32.20. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Cogent Biosciences, Inc. Common Stock?
Yes, Indian Investors can invest in the Cogent Biosciences, Inc. Common Stock (COGT) Share by opening an international trading account with Angel One.
How can I purchase Cogent Biosciences, Inc. Common Stock shares in India?
Purchasing Cogent Biosciences, Inc. Common Stock (COGT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cogent Biosciences, Inc. Common Stock (COGT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Cogent Biosciences, Inc. Common Stock?
Yes, you can purchase fractional shares of Cogent Biosciences, Inc. Common Stock (COGT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Cogent Biosciences, Inc. Common Stock?
The market capitalization of Cogent Biosciences, Inc. Common Stock on September 18, 2026, is $5.65 B.
In which sector Cogent Biosciences, Inc. Common Stock belongs?
Cogent Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Cogent Biosciences, Inc. Common Stock stocks?
In order to invest in Cogent Biosciences, Inc. Common Stock (COGT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
